C9X-31212-84545
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 939 / CA
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- ZN3-24550-74685
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-26
Registered in v-safe
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-09
-
2022-07-14
Dose 2 — Pfizer-BioNTech
- 2022-07-21
- 2022-07-28
- 2022-08-06
- 2022-08-11
-
2022-08-18
Survey response — day 35, dose 2, dependentMedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny nose/ coldMedDRA releases: 2024-11 · check-in free text available
- 2022-08-25
-
2022-10-13
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold with nasty cough.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-07-14 | Pfizer-BioNTech | No |
Free text
Release 12 — day 35, dose 2, dependent
Symptoms: Runny nose/ cold
Release 12 — 3 months, dose 2, dependent
Symptoms: Cold with nasty cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release